Isofol Medical AB
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.isofol.se
A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 490
- Registration Number
- NCT03750786
- Locations
- 🇺🇸
840-01 - HOAG Memorial Hospital, Newport Beach, California, United States
🇨🇦124-11 - CISSS de Chaudière-Appalaches, Lévis, Quebec, Canada
🇫🇷250-05 - Clinique Sainte Anne, Strasbourg, France
Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 33
- Registration Number
- NCT03203564
- Locations
- 🇸🇪
CTC Clinical Trial Consultants, Uppsala, Sweden
A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX
- Conditions
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2016-09-05
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 116
- Registration Number
- NCT02383901
- Locations
- 🇳🇴
Oslo University Hospital, Oslo, Norway
🇭🇺Semmelweis Egyetem II. Sz. Gyermekklinika, Budapest, Hungary
🇸🇪Karolinska University Hospital, Sweden, Stockholm, Sweden
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 105
- Registration Number
- NCT02244632
- Locations
- 🇬🇷
251 General Airforce Hospital, Athens, Greece
🇬🇷Metropolitan General Hospital, Athens, Greece
🇳🇴Oslo University Hospital - Radiumhospitalet, Oslo, Norway
Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
- Conditions
- Interventions
- First Posted Date
- 2013-11-19
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 18
- Registration Number
- NCT01987102
- Locations
- 🇨🇿
Fakultní nemocnice v Motole, Prague, Czechia
🇭🇺Semmelweis Egyetem II. Sz. Gyermekgyógyászati Klinika, Budapest, Hungary
🇨🇿Fakultní nemocnice Brno Klinika detske onkologie, Brno, Czechia
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
- Conditions
- Interventions
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 32
- Registration Number
- NCT01681472
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Sweden
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2011-07-19
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Isofol Medical AB
- Target Recruit Count
- 24
- Registration Number
- NCT01397305
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Göteborg, Sweden